2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow tominersen: new trials by email Literature Review of tominersen trials Research Report on tominersen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-Label Extension Study to Evaluate Long-Term Safety and Tolerability of RO7234292 (RG6042) in Huntington's Disease Participants Who Participated in Prior Roche and Genentech Sponsored Studies RO7234292 (RG6042) - Huntington Disease | Phase 3 | Completed | Hoffmann-La Roche | 236 | 2019-04-23 | 2023-08-31 |
| A Study to Evaluate the Efficacy and Safety of Intrathecally Administered RO7234292 (RG6042) in Participants With Manifest Huntington's Disease RO7234292, Placebo - Huntingtons Disease | Phase 3 | Completed | Hoffmann-La Roche | 899 | 2019-01-23 | 2024-03-01 |
Chorea (1) · Huntington Disease (1)
Austria (2) · Canada (2) · Germany (2) · Italy (2) · Netherlands (2) · Spain (2) · United Kingdom (2) · United States (2) · Argentina (1) · Australia (1) · Chile (1) · Denmark (1) · France (1) · Japan (1) · New Zealand (1)
PMID 30776019, PMID 31381524, PMID 42032152
2018 (1)